STYXL2 Gene

Name serine/threonine/tyrosine interacting like 2
Description Predicted to enable MAP kinase phosphatase activity and protein tyrosine/serine/threonine phosphatase activity. Predicted to be involved in negative regulation of MAPK cascade. Predicted to be located in sarcomere. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nExtensive investigation into antimicrobial peptides has revealed that beta‐defensins and cathelicidins play key roles in host defense by both directly eliminating pathogens and orchestrating immune cell recruitment via specific chemokine receptors, such as CCR2 and CCR6. For instance, studies have demonstrated that human beta‐defensin 2 and 3 (and their mouse orthologs) act as chemoattractants—engaging receptors on monocytes, macrophages, and even neutrophils—to coordinate innate and adaptive immune responses. These findings underscore the importance of such molecules in mediating inflammatory signals and facilitating leukocyte trafficking."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies have highlighted the dynamic expression of antimicrobial peptides during early development and disease. In neonatal skin, for example, enhanced levels of peptides such as cathelicidin and beta‐defensins offer compensatory defense mechanisms against bacterial pathogens, while ongoing expression in chronic infections like tuberculosis and fungal keratitis is closely linked to pathogen control and inflammation modulation. Moreover, tissue‐specific sources—including liver tissue following trauma—have been implicated in the postinjury upregulation of these peptides, further emphasizing the multifaceted regulation of innate immunity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nInterestingly, while genome‐wide association studies have begun to unravel genetic variants related to complex conditions like heroin addiction, none of the reviewed abstracts identify or describe a functional role for STYXL2 in these antimicrobial or immunomodulatory processes. In contrast to the clearly delineated functions of beta‐defensins and related peptides, STYXL2 remains uncharacterized within the context of these studies. This gap highlights the need for future research to investigate whether STYXL2, potentially as an atypical phosphatase or regulator, might interact with or modulate similar immune pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Johann Röhrl, De Yang, Joost J Oppenheim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0903984"}], "href": "https://doi.org/10.4049/jimmunol.0903984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20483750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20483750"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Johann Röhrl, De Yang, Joost J Oppenheim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.091090"}], "href": "https://doi.org/10.1074/jbc.M109.091090"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20068036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20068036"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Robert A Dorschner, Kenneth H Lin, Masamoto Murakami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1203/01.PDR.0000057205.64451.B7"}], "href": "https://doi.org/10.1203/01.PDR.0000057205.64451.B7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12612195"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12612195"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bruno Rivas-Santiago, Eduardo Sada, Victor Tsutsumi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "beta-Defensin gene expression during the course of experimental tuberculosis infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Infect Dis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/506454"}], "href": "https://doi.org/10.1086/506454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16897670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16897670"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Satya Sree N Kolar, Hasna Baidouri, Samuel Hanlon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Infect Immun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/IAI.00179-13"}], "href": "https://doi.org/10.1128/IAI.00179-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23670560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23670560"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Stefanie Fitschen-Oestern, Matthias Weuster, Sebastian Lippross, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocytes express the antimicrobial peptide HBD-2 after multiple trauma: an experimental study in human and mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Musculoskelet Disord (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12891-017-1458-8"}], "href": "https://doi.org/10.1186/s12891-017-1458-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28270138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28270138"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "David A Nielsen, Fei Ji, Vadim Yuferov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychiatr Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/YPG.0b013e32833a2106"}], "href": "https://doi.org/10.1097/YPG.0b013e32833a2106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20520587"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20520587"}]}]}]}
NCBI Gene ID 92235
API
Download Associations
Predicted Functions View STYXL2's ARCHS4 Predicted Functions.
Co-expressed Genes View STYXL2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View STYXL2's ARCHS4 Predicted Functions.

Functional Associations

STYXL2 has 1,315 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 19 datasets.

Click the + buttons to view associations for STYXL2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CellMarker Gene-Cell Type Associations cell types associated with STYXL2 gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of STYXL2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by STYXL2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
GO Biological Process Annotations 2023 biological processes involving STYXL2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving STYXL2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by STYXL2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by STYXL2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of STYXL2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of STYXL2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by STYXL2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of STYXL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of STYXL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by STYXL2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
PFOCR Pathway Figure Associations 2023 pathways involving STYXL2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving STYXL2 protein from the Wikipathways PFOCR 2024 dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of STYXL2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of STYXL2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of STYXL2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of STYXL2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.